18-51059974-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_005359.6(SMAD4):c.955+58C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0713 in 1,271,216 control chromosomes in the GnomAD database, including 3,562 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.054 ( 266 hom., cov: 32)
Exomes 𝑓: 0.074 ( 3296 hom. )
Consequence
SMAD4
NM_005359.6 intron
NM_005359.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.748
Publications
23 publications found
Genes affected
SMAD4 (HGNC:6770): (SMAD family member 4) This gene encodes a member of the Smad family of signal transduction proteins. Smad proteins are phosphorylated and activated by transmembrane serine-threonine receptor kinases in response to transforming growth factor (TGF)-beta signaling. The product of this gene forms homomeric complexes and heteromeric complexes with other activated Smad proteins, which then accumulate in the nucleus and regulate the transcription of target genes. This protein binds to DNA and recognizes an 8-bp palindromic sequence (GTCTAGAC) called the Smad-binding element (SBE). The protein acts as a tumor suppressor and inhibits epithelial cell proliferation. It may also have an inhibitory effect on tumors by reducing angiogenesis and increasing blood vessel hyperpermeability. The encoded protein is a crucial component of the bone morphogenetic protein signaling pathway. The Smad proteins are subject to complex regulation by post-translational modifications. Mutations or deletions in this gene have been shown to result in pancreatic cancer, juvenile polyposis syndrome, and hereditary hemorrhagic telangiectasia syndrome. [provided by RefSeq, May 2022]
SMAD4 Gene-Disease associations (from GenCC):
- juvenile polyposis/hereditary hemorrhagic telangiectasia syndromeInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp, G2P, PanelApp Australia
- Myhre syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
- generalized juvenile polyposis/juvenile polyposis coliInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
- juvenile polyposis syndromeInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- familial thoracic aortic aneurysm and aortic dissectionInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary hemorrhagic telangiectasiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- pulmonary arterial hypertensionInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 18-51059974-C-T is Benign according to our data. Variant chr18-51059974-C-T is described in ClinVar as [Benign]. Clinvar id is 1253468.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0792 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMAD4 | NM_005359.6 | c.955+58C>T | intron_variant | Intron 8 of 11 | ENST00000342988.8 | NP_005350.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0542 AC: 8234AN: 151920Hom.: 266 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
8234
AN:
151920
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0737 AC: 82453AN: 1119178Hom.: 3296 AF XY: 0.0728 AC XY: 41680AN XY: 572608 show subpopulations
GnomAD4 exome
AF:
AC:
82453
AN:
1119178
Hom.:
AF XY:
AC XY:
41680
AN XY:
572608
show subpopulations
African (AFR)
AF:
AC:
304
AN:
26710
American (AMR)
AF:
AC:
863
AN:
44170
Ashkenazi Jewish (ASJ)
AF:
AC:
1365
AN:
23970
East Asian (EAS)
AF:
AC:
1660
AN:
38006
South Asian (SAS)
AF:
AC:
3435
AN:
79028
European-Finnish (FIN)
AF:
AC:
4560
AN:
52796
Middle Eastern (MID)
AF:
AC:
142
AN:
5104
European-Non Finnish (NFE)
AF:
AC:
66811
AN:
800328
Other (OTH)
AF:
AC:
3313
AN:
49066
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
4019
8038
12056
16075
20094
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.0541 AC: 8230AN: 152038Hom.: 266 Cov.: 32 AF XY: 0.0533 AC XY: 3959AN XY: 74292 show subpopulations
GnomAD4 genome
AF:
AC:
8230
AN:
152038
Hom.:
Cov.:
32
AF XY:
AC XY:
3959
AN XY:
74292
show subpopulations
African (AFR)
AF:
AC:
609
AN:
41482
American (AMR)
AF:
AC:
422
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
AC:
165
AN:
3470
East Asian (EAS)
AF:
AC:
229
AN:
5174
South Asian (SAS)
AF:
AC:
235
AN:
4818
European-Finnish (FIN)
AF:
AC:
905
AN:
10546
Middle Eastern (MID)
AF:
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
AC:
5507
AN:
67962
Other (OTH)
AF:
AC:
72
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
414
829
1243
1658
2072
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
113
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.